Drug Pricing

Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Commentary

Read latest about problems with PBMs

Pharmacy benefit manager reform must remain a priority for Congress

Congress has returned to Capitol Hill from summer recess. Lawmakers in both chambers have a full slate of policy priorities to attend to — not least among them funding the government and averting a shutdown before the Sept. 30 deadline. Several healthcare items will also remain near the top of ...
Commentary

Government Regulation Threatens Life-Saving Innovation

Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.

New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Commentary

Learn how price controls threaten access to drugs

Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.

President Joe Biden celebrated a milestone today—but American patients have no reason to cheer. The White House announced the first 10 prescription drugs that, starting in 2026, will be subject to price controls authorized by the Inflation Reduction Act . . . It’s laudable that lawmakers want to reduce out-of-pocket ...
Commentary

Read latest on government price controls

Medicaid Drug Price Transparency Rule Is More Sinister Than It Seems

The Biden administration claims to support price transparency in healthcare. The Centers for Medicare and Medicaid Services has formally warned hundreds of hospitals to comply with federal rules requiring them to post their prices publicly. And the agency just rolled out a new rule designed to “advance prescription drug transparency ...
Commentary

Read the latest about PBMs

It’s Time To End the PBM Shakedown

Who says bipartisanship is dead? In the House and Senate, members of both parties are advancing legislation to check the power of pharmacy benefit managers (PBMs), the self-dealing middlemen in the drug supply chain that inflate Americans’ spending on prescriptions by billions of dollars a year. By shining a light ...
Blog

Read more about broken 340B program

340B Advocates Strike Back

There are many reasons why government programs fail to deliver on their intentions, regardless of how well meaning they may be. The rhetoric from too many 340B recipients exemplifies a primary obstacle: Reforms that are necessary to correct a program’s glaring flaws or its fundamental unsustainability are demagogued and labeled ...
Commentary

PBM Industry Shadowy, Congress Shines Much Needed Light

The last few months have seen a flurry of activity on Capitol Hill regarding prescription drug reform, with a particular focus on pharmacy benefit managers, or PBMs. The U.S. Senate Finance Committee is set to markup a bipartisan PBM reform bill within the next few days. The House Energy and Commerce ...
Commentary

Imposing Price Controls Is Never The Answer

The Senate Health, Education, Labor, and Pensions (HELP) Committee is currently reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA), which is supposed to help us prepare for the next public health emergency. Never missing an opportunity to impose price controls on anything and everything, Senator Bernie Sanders (I-VT) wants to ...
Commentary

Democrats want to take medicinal price controls further

Senate Democrats Take One More Step Toward Socialized Medicine

It’s been less than a year since Democrats enacted the Inflation Reduction Act, which gives Medicare the power to set the prices of certain medicines. Those price controls have yet to go into effect. But Democrats already want more. They’ve introduced new legislation that would amp up those price controls ...
Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Commentary

Read latest about problems with PBMs

Pharmacy benefit manager reform must remain a priority for Congress

Congress has returned to Capitol Hill from summer recess. Lawmakers in both chambers have a full slate of policy priorities to attend to — not least among them funding the government and averting a shutdown before the Sept. 30 deadline. Several healthcare items will also remain near the top of ...
Commentary

Government Regulation Threatens Life-Saving Innovation

Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.

New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Commentary

Learn how price controls threaten access to drugs

Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.

President Joe Biden celebrated a milestone today—but American patients have no reason to cheer. The White House announced the first 10 prescription drugs that, starting in 2026, will be subject to price controls authorized by the Inflation Reduction Act . . . It’s laudable that lawmakers want to reduce out-of-pocket ...
Commentary

Read latest on government price controls

Medicaid Drug Price Transparency Rule Is More Sinister Than It Seems

The Biden administration claims to support price transparency in healthcare. The Centers for Medicare and Medicaid Services has formally warned hundreds of hospitals to comply with federal rules requiring them to post their prices publicly. And the agency just rolled out a new rule designed to “advance prescription drug transparency ...
Commentary

Read the latest about PBMs

It’s Time To End the PBM Shakedown

Who says bipartisanship is dead? In the House and Senate, members of both parties are advancing legislation to check the power of pharmacy benefit managers (PBMs), the self-dealing middlemen in the drug supply chain that inflate Americans’ spending on prescriptions by billions of dollars a year. By shining a light ...
Blog

Read more about broken 340B program

340B Advocates Strike Back

There are many reasons why government programs fail to deliver on their intentions, regardless of how well meaning they may be. The rhetoric from too many 340B recipients exemplifies a primary obstacle: Reforms that are necessary to correct a program’s glaring flaws or its fundamental unsustainability are demagogued and labeled ...
Commentary

PBM Industry Shadowy, Congress Shines Much Needed Light

The last few months have seen a flurry of activity on Capitol Hill regarding prescription drug reform, with a particular focus on pharmacy benefit managers, or PBMs. The U.S. Senate Finance Committee is set to markup a bipartisan PBM reform bill within the next few days. The House Energy and Commerce ...
Commentary

Imposing Price Controls Is Never The Answer

The Senate Health, Education, Labor, and Pensions (HELP) Committee is currently reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA), which is supposed to help us prepare for the next public health emergency. Never missing an opportunity to impose price controls on anything and everything, Senator Bernie Sanders (I-VT) wants to ...
Commentary

Democrats want to take medicinal price controls further

Senate Democrats Take One More Step Toward Socialized Medicine

It’s been less than a year since Democrats enacted the Inflation Reduction Act, which gives Medicare the power to set the prices of certain medicines. Those price controls have yet to go into effect. But Democrats already want more. They’ve introduced new legislation that would amp up those price controls ...
Scroll to Top